SITC Archive Library

Back to Library

First-in-class inhibitors of ERAP1 Modify the Tumor-specific Surfaceome, Driving a Differentiated T Cell Response and Tumor Growth Inhibition 

09-24-2021 10:57

First-in-class inhibitors of ERAP1 Modify the Tumor-specific Surfaceome, Driving a Differentiated T Cell Response and Tumor Growth Inhibition: Andrew Leishman PhD, Wayne Paes PhD, Jessica Sette, Kate Anderton, Nicola Ternette PhD, Kris Clark PhD, Carmen Tong PhD, Jason Shiers PhD, Martin Quibell PhD, Peter Joyce PhD.

Andrew Leishman PhD, Jessica Sette, Kate Anderton, Martin Quibell PhD, Peter Joyce PhD. - Grey Wolf Therapeutics, Oxford UK
Wayne Paes PhD, Nicola Ternette PhD - University of Oxford, Oxford, UK
Kris Clark PhD, Carmen Tong PhD, Jason Shiers PhD. - Sygnature Discovery, Nottinham, UK

Statistics
0 Favorited
25 Views
1 Files
0 Shares
8 Downloads
Attachment(s)
pdf file
First-in-class inhibitors of ERAP1 Modify the Tumor-speci...   40.00 MB   1 version
Uploaded - 09-24-2021
Andrew Leishman PhD, Wayne Paes PhD, Jessica Sette, Kate Anderton, Nicola Ternette PhD, Kris Clark PhD, Carmen Tong PhD, Jason Shiers PhD, Martin Quibell PhD, Peter Joyce PhD.
 
Download

Related Entries and Links

No Related Resource entered.